|Articles|October 1, 2006

Pharmacy Times

  • Volume 0
  • 0

TIAs: WHAT TO DO WHEN ASPIRIN IS NOT ENOUGH

Patients who experience transient ischemic attacks (TIAs) are at high risk for stroke and need preventive therapy. Aspirin is commonly used to reduce the risk of stroke in these patients. Some patients, however, may continue to experience TIAs while on aspirin therapy. Data regarding the efficacy of other antiplatelet therapies such as dipyridamole, ticlopidine, or clopidogrel in combination with aspirin are limited.

The American Heart Association recognizes the lack of evidence in this area. It recommends therapy be individualized for each patient to receive either the combination of extended-release dipyridamole and aspirin or clopidogrel 75 mg daily for secondary prevention. Clopidogrel is recommended over ticlopidine because it has a better safety profile.

Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.

Articles in this issue

about 19 years ago

Rx Product News

about 19 years ago

OTC Product News

about 19 years ago

can you READ these Rxs?

about 19 years ago

Juvenile Anabolic Steroid Abuse

about 19 years ago

Compounding Hotline

about 19 years ago

Ouch! Time for Flu Shots

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME